← FDA Drug Approvals (Drugs@FDA)

BEQALZI

NDA · New Drug Application · Sponsor: BEONE MEDICINES USA · Approved 2026-05-13

Drug application

FDA Application #

NDA220711

Application type

New Drug Application

Brand name

BEQALZI

Generic name

Sonrotoclax

Active ingredients

SONROTOCLAX

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

BEONE MEDICINES USA

First approval

2026-05-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown